Esra C. Aydin

Rize, Turkey

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Prognostic factors in avelumab maintenance therapy for metastatic urothelial carcinoma.

Prognostic factors in avelumab maintenance therapy for metastatic urothelial carcinoma.

Journal: Immunotherapy

Published: September 02, 2026

Prognostic Significance of the CPS-EG Score in Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy.

Prognostic Significance of the CPS-EG Score in Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy.

Journal: Cancers

Published: June 09, 2026

Real-World Outcomes of CDK4/6 Inhibitors in Germline BRCA1/2-Mutated Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study.

Real-World Outcomes of CDK4/6 Inhibitors in Germline BRCA1/2-Mutated Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study.

Journal: Current oncology (Toronto, Ont.)

Published: May 02, 2026

Clinical Impact of PSMA PET Fusion-Based RT Planning on Dosimetry and PSA Response in Prostate Cancer.

Clinical Impact of PSMA PET Fusion-Based RT Planning on Dosimetry and PSA Response in Prostate Cancer.

Journal: Journal of clinical medicine

Published: March 21, 2026

Facing death: the last drawings of a woman with breast cancer at the end of life.

Facing death: the last drawings of a woman with breast cancer at the end of life.

Journal: NPJ breast cancer

Published: January 23, 2026

Relationship between overall survival and progression-free survival with 18 F-FDG PET/CT metabolic parameters in metastatic breast cancer patients treated with CDK 4/6 inhibitors.

Relationship between overall survival and progression-free survival with 18 F-FDG PET/CT metabolic parameters in metastatic breast cancer patients treated with CDK 4/6 inhibitors.

Journal: Irish journal of medical science

Published: January 02, 2026

Sarcopenia is a bad harbinger of cancer-related survival in rectal cancer.

Sarcopenia is a bad harbinger of cancer-related survival in rectal cancer.

Journal: Annals of medicine

Published: December 19, 2025

The Inferior Pedicled Dermal Flap: Revisiting a Versatile Technique for Nipple- and Skin-Sparing Mastectomy in Breast Reconstruction.

The Inferior Pedicled Dermal Flap: Revisiting a Versatile Technique for Nipple- and Skin-Sparing Mastectomy in Breast Reconstruction.

Journal: Plastic and reconstructive surgery

Published: October 31, 2025

Avelumab maintenance in patients with metastatic urothelial carcinoma in a real-life expanded-access program.

Avelumab maintenance in patients with metastatic urothelial carcinoma in a real-life expanded-access program.

Journal: Future oncology (London, England)

Published: October 17, 2025

Author Correction: The prognostic impact of Her2 status in early triple negative breast cancer: a Turkish Oncology Group (TOG) study.

Author Correction: The prognostic impact of Her2 status in early triple negative breast cancer: a Turkish Oncology Group (TOG) study.

Journal: Scientific reports

Published: March 19, 2025

Activity of CDK4/6 inhibitors and parameters affecting survival in elderly patients in age-subgroups: Turkish Oncology Group (TOG) retrospective study.

Activity of CDK4/6 inhibitors and parameters affecting survival in elderly patients in age-subgroups: Turkish Oncology Group (TOG) retrospective study.

Journal: BMC cancer

Published: August 03, 2024

Tumor-stroma type and tumor-stroma ratio predict neoadjuvant chemotherapy response in breast cancer.

Tumor-stroma type and tumor-stroma ratio predict neoadjuvant chemotherapy response in breast cancer.

Journal: Revista da Associacao Medica Brasileira (1992)

Published: July 18, 2024

Showing 1-12 of 36

Last Updated: 09/26/2026